<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7129111/results/search/test_trace/results.xml">
  <result pre="was highly spoken as &quot;an amazing achievement&quot; by WHO. Clinical" exact="treatment" post="and management of COVID-19 hospitalized patients is constituting a"/>
  <result pre="hospitalized treatment, pharmaceutical care services are indispensable supplement for clinical" exact="treatment" post="and management, which is of great significance for improving"/>
  <result pre="the overall pandemic control. Detailed and feasible suggestions on clinical" exact="diagnosis" post="and treatment were provided in clinical management guidance from"/>
  <result pre="pandemic control. Detailed and feasible suggestions on clinical diagnosis and" exact="treatment" post="were provided in clinical management guidance from National Health"/>
  <result pre="framework of COVID-19 hospitalized patients for hospital pharmacists After the" exact="diagnosis" post="of COVID-19 infection, patients need to be admitted to"/>
  <result pre="of COVID-19 patients is also an important factor affecting the" exact="treatment" post="and prognosis of the disease. It's necessary for hospital"/>
  <result pre="clinical experience and patients’ individual characteristics, providing patients with evidence-based" exact="treatment" post="and care is of great significance. As a member"/>
  <result pre="of Health-System Pharmacist (ASHP) provided an evidence table for COVID-19-related" exact="treatment" post="to help practitioners better understand current treatment options.12 Based"/>
  <result pre="table for COVID-19-related treatment to help practitioners better understand current" exact="treatment" post="options.12 Based on these available evidence, hospital pharmacists should"/>
  <result pre="the results of lopinavir-ritonavir, arbidol and Hydroxychloroquine sulfate on COVID-19" exact="treatment" post="have been reported in 6 studies.14, 15, 16, 17,"/>
  <result pre="controlled, open-label trial14 suggested, for patients with severe COVID-19, lopinavir-ritonavir" exact="treatment" post="beyond standard care did not significantly accelerate clinical improvement"/>
  <result pre="of viral nucleic acid turning negative among arbidol treatment, lopinavir-ritonavir" exact="treatment" post="and control group (P &amp;gt; 0.05). For hydroxychloroquine sulfate:"/>
  <result pre="oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the" exact="treatment" post="of COVID-19.20 Hospital pharmacists should combine the available evidence,"/>
  <result pre="systemic corticosteroids are not recommended to be routinely used for" exact="treatment" post="of viral pneumonia outside of clinical trials. CDC guidance9"/>
  <result pre="recommended that inappropriate use of antibiotics should be avoided. Etiological" exact="tests" post="should be taken if necessary, and antibiotics should be"/>
  <result pre="effective therapy choice, and has been successfully applied to the" exact="treatment" post="of SARS and H1N1 influenza.27 Before conducting CPT, pharmacists"/>
  <result pre="with COVID-19, pharmaceutical care services are indispensable supplements for clinical" exact="treatment" post="and management. Hospital pharmacists providing targeted pharmaceutical care is"/>
  <result pre="7National Health Commission of the People’s Republic of ChinaDiagnosis and" exact="treatment" post="protocol for COVID-19 (trial version 7)https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf2020 8World Health OrganizationClinical"/>
  <result pre="version 7)https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf2020 8World Health OrganizationClinical management of severe acute respiratory" exact="infection" post="(SARI) when COVID-19 disease is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers for Disease"/>
  <result pre="Clin Infect Dis2020 17ChenJ.LingY.XiX.H.Efficacies of lopinavir/ritonavir and abidol in the" exact="treatment" post="of novel coronavirus pneumoniaChin J of Infect Dis2020 18GautretP.LagierJ.-C.ParolaP.Hydroxychloroquine"/>
  <result pre="pneumoniaChin J of Infect Dis2020 18GautretP.LagierJ.-C.ParolaP.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
  <result pre="trialInt J Antimicrob Agents2020 19ChenJ.LiuD.P.LiuL.A pilot study of hydroxychloroquine in" exact="treatment" post="of patients with common coronavirus disease-19 (COVID-19)Journal of Zhejaing"/>
  <result pre="gynecology, Chinese medical doctor association. Proposed management of 2019-novel coronavirus" exact="infection" post="during pregnancy and puerperiumChin J Prev Med2320207379 24Chinese Pharmaceutical"/>
 </snippets>
</snippetsTree>
